Intellia doses the first patient in the phase III HAELO study on NTLA-2002 for treating hereditary angioedema. Stock rises.
Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR ...
From understanding the impact of the Secure Acts to planning for required distributions, this guide will help you navigate the complexities of non-spouse inherited IRAs. If you have also inherited ...
Myelin is an insulating layer of lipids and proteins surrounding nerves. Myelin damage can cause problems with the nerves’ ability to send and receive electrical messages. Inflammatory disorders ...
RESULTS Thirty seven patients were diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), four ... three with chronic inflammatory demyelinating polyneuropathy (CIDP), and one ...
This study was designed to evaluate the incidence and character of peripheral neuropathy in patients with liver cirrhosis. The effect of alcohol consumption, severity of liver disease and ...
Alistair Berg / Getty Images Women stand to inherit roughly $40 trillion from their spouses during the Great Wealth Transfer, Cerulli Associates found. The Great Wealth Transfer refers to the ...